Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer

被引:96
作者
Bilotta, Maria Teresa [1 ,4 ]
Petillo, Sara [1 ]
Santoni, Angela [1 ,2 ,3 ]
Cippitelli, Marco [1 ]
机构
[1] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
[2] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy
[3] Ist Mediterraneo Neurosci Neuromed, Pozzilli, Italy
[4] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
关键词
liver-X-receptor; cholesterol; inflammation; autoimmunity; cancer metabolism; antitumor immune responses; COLLAGEN-INDUCED ARTHRITIS; OXYSTEROL-SIGNALING PATHWAY; NUCLEAR RECEPTOR; LXR-ALPHA; GENE-EXPRESSION; ACTIVATION; CELLS; PROLIFERATION; INNATE; ATHEROSCLEROSIS;
D O I
10.3389/fimmu.2020.584303
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interplay between cellular stress and immune response can be variable and sometimes contradictory. The mechanisms by which stress-activated pathways regulate the inflammatory response to a pathogen, in autoimmunity or during cancer progression remain unclear in many aspects, despite our recent knowledge of the signalling and transcriptional pathways involved in these diseases. In this context, over the last decade many studies demonstrated that cholesterol metabolism is an important checkpoint for immune homeostasis and cancer progression. Indeed, cholesterol is actively metabolized and can regulate, through its mobilization and/or production of active derivatives, many aspects of immunity and inflammation. Moreover, accumulation of cholesterol has been described in cancer cells, indicating metabolic addiction. The nuclear receptors liver-X-receptors (LXRs) are important regulators of intracellular cholesterol and lipids homeostasis. They have also key regulatory roles in immune response, as they can regulate inflammation, innate and adaptive immunity. Moreover, activation of LXRs has been reported to affect the proliferation and survival of different cancer cell types that show altered metabolic pathways and accumulation of cholesterol. In this minireview we will give an overview of the recent understandings about the mechanisms through which LXRs regulate inflammation, autoimmunity, and cancer, and the therapeutic potential for future treatment of these diseases through modulation of cholesterol metabolism.
引用
收藏
页数:10
相关论文
共 111 条
  • [71] The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms
    Pourcet, Benoit
    Gage, Matthew C.
    Leon, Theresa E.
    Waddington, Kirsty E.
    Pello, Oscar M.
    Steffensen, Knut R.
    Castrillo, Antonio
    Valledor, Annabel F.
    Pineda-Torra, Ines
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [72] The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
    Raccosta, Laura
    Fontana, Raffaella
    Maggioni, Daniela
    Lanterna, Claudia
    Villablanca, Eduardo J.
    Paniccia, Aida
    Musumeci, Andrea
    Chiricozzi, Elena
    Trincavelli, Maria Letizia
    Daniele, Simona
    Martini, Claudia
    Gustafsson, Jan-Ake
    Doglioni, Claudio
    Feo, Safiye Gonzalvo
    Leiva, Andrea
    Ciampa, Maria Grazia
    Mauri, Laura
    Sensi, Cristina
    Prinetti, Alessandro
    Eberini, Ivano
    Mora, J. Rodrigo
    Bordignon, Claudio
    Steffensen, Knut R.
    Sonnino, Sandro
    Sozzani, Silvano
    Traversari, Catia
    Russo, Vincenzo
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (09) : 1711 - 1728
  • [73] 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon
    Reboldi, Andrea
    Dang, Eric V.
    McDonald, Jeffrey G.
    Liang, Guosheng
    Russell, David W.
    Cyster, Jason G.
    [J]. SCIENCE, 2014, 345 (6197) : 679 - 684
  • [74] A structural equation model to assess the pathways of body adiposity and inflammation status on dysmetabolic biomarkers via red cell distribution width and mean corpuscular volume: a cross-sectional study in overweight and obese subjects
    Rondanelli, Mariangela
    Perna, Simone
    Alalwan, Tariq A.
    Cazzola, Roberta
    Gasparri, Clara
    Infantino, Vittoria
    Perdoni, Federica
    Iannello, Giancarlo
    Pepe, Daniele
    Guido, Davide
    [J]. LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [75] LXRs Regulate ER Stress and Inflammation through Dynamic Modulation of Membrane Phospholipid Composition
    Rong, Xin
    Albert, Carolyn J.
    Hong, Cynthia
    Duerr, Mark A.
    Chamberlain, Brian T.
    Tarling, Elizabeth J.
    Ito, Ayaka
    Gao, Jie
    Wang, Bo
    Edwards, Peter A.
    Jung, Michael E.
    Ford, David A.
    Tontonoz, Peter
    [J]. CELL METABOLISM, 2013, 18 (05) : 685 - 697
  • [76] Role of LXRs in control of lipogenesis
    Schultz, JR
    Tu, H
    Luk, A
    Repa, JJ
    Medina, JC
    Li, LP
    Schwendner, S
    Wang, S
    Thoolen, M
    Mangelsdorf, DJ
    Lustig, KD
    Shan, B
    [J]. GENES & DEVELOPMENT, 2000, 14 (22) : 2831 - 2838
  • [77] Lipid Mediators in the Resolution of Inflammation
    Serhan, Charles N.
    Chiang, Nan
    Dalli, Jesmond
    Levy, Bruce D.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (02):
  • [78] Pro-resolving lipid mediators are leads for resolution physiology
    Serhan, Charles N.
    [J]. NATURE, 2014, 510 (7503) : 92 - 101
  • [79] Smolen JS, 2016, LANCET, V388, P1984
  • [80] LXR-Mediated Inhibition of CD4+ T Helper Cells
    Solt, Laura A.
    Kamenecka, Theodore M.
    Burris, Thomas P.
    [J]. PLOS ONE, 2012, 7 (09):